Cart
sales@molnova.com
CCT077791
CAS No. 748777-47-1
CCT077791( —— )
Catalog No. M34060 CAS No. 748777-47-1
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCT077791
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain | Histone Acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number748777-47-1
-
Formula Weight256.67
-
Molecular FormulaC9H5ClN2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(SC(Cl)=C1)C2=CC=C(N(=O)=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
JWG-071
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
-
PBRM1-BD2-IN-8
PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor with PBRM1-BD2 Kd of 4.4 μM, PBRM1-BD2 IC50 of 0.16 μM, and PBRM1-BD5 Kd of 25 μM; PBRM1-BD2-IN-8 shows anti-cancer activity.
-
JQAD1
JQAD1 is a potent and selective histone acetyltransferase EP300 degrader (PROTAC?; DC50≤ 31.6 nM); comprises an EP300 inhibitor, A485, joined by a linker to a cereblon E3 ligase ligand.
